| [1] |
Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 [J]. The Lancet, 2014, 384(9945): 766-781.
|
| [2] |
Bhaskaran K, Douglas I, Forbes H, et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults [J]. The Lancet, 2014, 384(9945): 755-765.
|
| [3] |
Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study [J]. The Lancet Oncology, 2015, 16(1): 36-46.
|
| [4] |
Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body Fatness and Cancer — Viewpoint of the IARC Working Group [J]. New England Journal of Medicine, 2016, 375(8): 794-798.
|
| [5] |
Hotamisligil GS. Inflammation and metabolic disorders [J]. Nature, 2006, 444(7121): 860-867.
|
| [6] |
Kryston TB, Georgiev AB, Pissis P, et al. Role of oxidative stress and DNA damage in human carcinogenesis [J]. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2011, 711(1-2): 193-201.
|
| [7] |
Savini I, Catani M, Evangelista D, et al. Obesity-Associated Oxidative Stress: Strategies Finalized to Improve Redox State [J]. International Journal of Molecular Sciences, 2013, 14(5): 10497-10538.
|
| [8] |
Luperini BCO, Almeida DC, Porto MP, et al. Gene polymorphisms and increased DNA damage in morbidly obese women [J]. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2015, 776(1-2): 111-117.
|
| [9] |
Pelucchi C, Serraino D, Negri E, et al. The Metabolic Syndrome and Risk of Prostate Cancer in Italy [J]. Annals of Epidemiology, 2011, 21(11): 835-841.
|
| [10] |
Tian Y, Wang K, Li J, et al. The association between serum lipids and colorectal neoplasm: a systemic review and meta-analysis [J]. Public Health Nutrition, 2015, 18(18): 3355-3370.
|
| [11] |
Gallagher EJ, Zelenko Z, Neel BA, et al. Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia [J]. Oncogene, 2017, 36(46): 6462-6471.
|
| [12] |
Jin Y, Yang T, Li D, et al. Effect of dietary cholesterol intake on the risk of esophageal cancer: a meta-analysis [J]. Journal of International Medical Research, 2019, 47(9): 4059-4068.
|
| [13] |
Ringel AE, Drijvers JM, Baker GJ, et al. Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity [J]. Cell, 2020, 183(7): 1848-1866. e26.
|
| [14] |
Danilo C, Gutierrez-Pajares JL, Mainieri MA, et al. Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development [J]. Breast Cancer Research, 2013, 15(5): R87.
|
| [15] |
Gordon JA, Noble JW, Midha A, et al. Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate Cancer [J]. Cancer Research, 2019, 79(13): 3320-3331.
|
| [16] |
Guillaumond F, Bidaut G, Ouaissi M, et al. Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma [J]. Proceedings of the National Academy of Sciences, 2015, 112(8): 2473-2478.
|
| [17] |
Graziani SR, Igreja FAF, Hegg R, et al. Uptake of a Cholesterol-Rich Emulsion by Breast Cancer [J]. Gynecologic Oncology, 2002, 85(3): 493-497.
|
| [18] |
Pascual G, Avgustinova A, Mejetta S, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36 [J]. Nature, 2017, 541(7635): 41-45.
|
| [19] |
Ladanyi A, Mukherjee A, Kenny HA, et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis [J]. Oncogene, 2018, 37(17): 2285-2301.
|
| [20] |
Michelet X, Dyck L, Hogan A, et al. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses [J]. Nature Immunology, 2018, 19(12): 1330-1340.
|
| [21] |
Wang H, Franco F, Tsui Y-C, et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors [J]. Nature Immunology, 2020, 21(3): 298-308.
|
| [22] |
Iyengar P, Espina V, Williams TW, et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment [J]. Journal of Clinical Investigation, 2005, 115(5): 1163-1176.
|
| [23] |
Sheng X, Parmentier J-H, Tucci J, et al. Adipocytes Sequester and Metabolize the Chemotherapeutic Daunorubicin [J]. Molecular Cancer Research, 2017, 15(12): 1704-1713.
|
| [24] |
Su F, Ahn S, Saha A, et al. Adipose stromal cell targeting suppresses prostate cancer epithelial-mesenchymal transition and chemoresistance [J]. Oncogene, 2019, 38(11): 1979-1988.
|
| [25] |
Reggiani F, Labanca V, Mancuso P, et al. Adipose Progenitor Cell Secretion of GM-CSF and MMP9 Promotes a Stromal and Immunological Microenvironment That Supports Breast Cancer Progression [J]. Cancer Research, 2017, 77(18): 5169-5182.
|
| [26] |
Saha A, Ahn S, Blando J, et al. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice [J]. Cancer Research, 2017, 77(18): 5158-5168.
|
| [27] |
Qian B-Z, Pollard JW. Macrophage Diversity Enhances Tumor Progression and Metastasis [J]. Cell, 2010, 141(1): 39-51.
|
| [28] |
Arendt LM, McCready J, Keller PJ, et al. Obesity Promotes Breast Cancer by CCL2-Mediated Macrophage Recruitment and Angiogenesis [J]. Cancer Research, 2013, 73(19): 6080-6093.
|
| [29] |
Kuang D-M, Zhao Q, Peng C, et al. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1 [J]. Journal of Experimental Medicine, 2009, 206(6): 1327-1337.
|
| [30] |
Springer NL, Iyengar NM, Bareja R, et al. Obesity-Associated Extracellular Matrix Remodeling Promotes a Macrophage Phenotype Similar to Tumor-Associated Macrophages [J]. The American Journal of Pathology, 2019, 189(10): 2019-2035.
|
| [31] |
Iyengar NM, Zhou XK, Gucalp A, et al. Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer [J]. Clinical Cancer Research, 2016, 22(9): 2283-2289.
|
| [32] |
Morris PG, Hudis CA, Giri D, et al. Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer [J]. Cancer Prevention Research, 2011, 4(7): 1021-1029.
|
| [33] |
Bowers LW, Brenner AJ, Hursting SD, et al. Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production [J]. Breast Cancer Research and Treatment, 2015, 149(1): 49-57.
|
| [34] |
Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects [J]. Nature Medicine, 1995, 1(11): 1155-1161.
|
| [35] |
Andò S, Gelsomino L, Panza S, et al. Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms [J]. Cancers, 2019, 11(1): 62.
|
| [36] |
Zheng Q, Dunlap SM, Zhu J, et al. Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival [J]. Endocrine-Related Cancer, 2011, 18(4): 491-503.
|
| [37] |
Wang Z, Aguilar EG, Luna JI, et al. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade [J]. Nature Medicine, 2019, 25(1): 141-151.
|
| [38] |
Murphy KA, James BR, Sjaastad FV, et al. Cutting Edge: Elevated Leptin during Diet-Induced Obesity Reduces the Efficacy of Tumor Immunotherapy [J]. The Journal of Immunology, 2018, 201(7): 1837-1841.
|
| [39] |
Wrann CD, Laue T, Hübner L, et al. Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions [J]. American Journal of Physiology-Endocrinology and Metabolism, 2012, 302(1): E108-E116.
|
| [40] |
Sepesi B, Gold K A, Correa A M, et al. The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer [J]. Journal of Thoracic Oncology, 2017, 12(8): 1280-1287.
|
| [41] |
McQuade JL, Daniel CR, Hess KR, et al. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis [J]. The Lancet Oncology, 2018, 19(3): 310-322.
|
| [42] |
Kichenadasse G, Miners JO, Mangoni AA, et al. Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer [J]. JAMA Oncology, 2020, 6(4): 512.
|
| [43] |
Webb PM. Commentary: Weight gain, weight loss, and endometrial cancer[J]. International Journal of Epidemiology, 2006, 35(1): 166-168.
|
| [44] |
Sjöström L, Larsson B, Carlsson B, et al. Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects [J]. New England Journal of Medicine, 2007, 357(8): 741-752.
|
| [45] |
Adams TD, Stroup AM, Gress RE, et al. Cancer Incidence and Mortality After Gastric Bypass Surgery [J]. Obesity, 2009, 17(4): 796-802.
|
| [46] |
Aminian A, Wilson R, Al-Kurd A, et al. Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity [J]. JAMA, 2022, 327(24): 2423.
|
| [47] |
Bonovas S, Filioussi K, Sitaras NM. Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies: Statin Use and Prostate Cancer Risk [J]. International Journal of Cancer, 2008, 123(4): 899-904.
|
| [48] |
Manthravadi S, Shrestha A, Madhusudhana S. Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis: Breast cancer: A systematic review and meta-analysis [J]. International Journal of Cancer, 2016, 139(6): 1281-1288.
|
| [49] |
Scully T, Ettela A, LeRoith D, et al. Obesity, Type 2 Diabetes, and Cancer Risk [J]. Frontiers in Oncology, 2021, 10: 615375.
|
| [50] |
Lengyel E, Makowski L, DiGiovanni J, et al. Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors [J]. Trends in Cancer, 2018, 4(5): 374-384.
|
| [51] |
Quail DF, Dannenberg AJ. The obese adipose tissue microenvironment in cancer development and progression [J]. Nature Reviews Endocrinology, 2019, 15(3): 139-154.
|
| [52] |
Stancu C, Sima A. Statins: mechanism of action and effects [J]. Journal of Cellular and Molecular Medicine, 2001, 5(4): 378-387.
|
| [53] |
Murtola TJ, Syvälä H, Pennanen P, et al. The Importance of LDL and Cholesterol Metabolism for Prostate Epithelial Cell Growth [J]. I. Agoulnik. PLoS ONE, 2012, 7(6): e39445.
|